DongBang Medical
Financials
Valuation Metrics
DongBang Medical's Market Cap is ₩1057B. At end of 2025 it was ₩1635B. Ranked #1179 of 2,405 in KR market (top 49%), #623 of 1,627 on KOSDAQ (top 38%), #41 of 94 in Health Care Equipment & Services (top 44%) by Market Cap.
Investment Metrics(as of 2026-11-02)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 105.72B KRW | KR#1,179/2,405 Sec#41/94 |
| Revenue | 125.12B KRW | KR#1,286/2,405 Sec#23/94 |
| Net Income | 15.61B KRW | KR#803/2,405 Sec#21/94 |
| Total Assets | 186.53B KRW | KR#1,363/2,405 Sec#38/94 |
| Net Assets | 125.32B KRW | KR#1,263/2,405 Sec#38/94 |
| Employees | 284 | KR#831/2,405 Sec#24/94 |
| Value | ||
| P/E | 6.77x | KR#599/2,405 Sec#15/94 |
| P/B | 0.84x | KR#1,383/2,405 Sec#34/94 |
| PEG | 0.02x | KR#217/2,405 Sec#10/94 |
| P/S | 0.84x | KR#1,334/2,405 Sec#22/94 |
| EV/EBITDA | 4.84x | KR#257/2,405 Sec#9/94 |
| Profitability | ||
| ROE | 12.46% | KR#445/2,405 Sec#19/94 |
| ROA | 8.37% | KR#405/2,405 Sec#23/94 |
| Op. Margin | 17.59% | KR#214/2,405 Sec#19/94 |
| Revenue Growth | 8.01% | KR#1,011/2,405 Sec#57/94 |
| Earnings Growth | 292.63% | KR#169/2,405 Sec#9/94 |
| Financial Health | ||
| Debt Ratio | 48.85% | KR#940/2,405 Sec#52/94 |
| Total Debt | 31.42B KRW | KR#1,202/2,405 Sec#29/94 |
| Cash | 30.64B KRW | KR#1,001/2,405 Sec#26/94 |
| Current Ratio | 2.04x | KR#846/2,405 Sec#49/94 |
| Net Debt/EBITDA | 0.04x | KR#609/2,405 Sec#24/94 |
| Performance | ||
| 1Y Return | -46.79% | KR#1,862/2,405 Sec#63/94 |
| 1M Return | -20.47% | KR#1,897/2,405 Sec#79/94 |
| From 52W High | -49.70% | KR#1,171/2,405 Sec#41/94 |
| 1Y MDD | -50.83% | KR#992/2,405 Sec#37/94 |
| Trading | ||
| Volume | 29,611 shares | KR#1,282/2,405 Sec#45/94 |
| Trading Value | 148.5M KRW | KR#1,260/2,405 Sec#49/94 |
| Foreign Own. | 1.08% | KR#1,995/2,405 Sec#75/94 |
| Per Share | ||
| EPS | 746 KRW | KR#843/2,405 Sec#20/94 |
| BPS | 5,986 KRW | KR#1,372/2,405 Sec#33/94 |
Company Info
Dongbang Medical, established in 1985 and converted into a corporation in 2014, listed on the KOSDAQ market in 2025. The company primarily focuses on manufacturing and selling traditional Korean medicine medical devices and aesthetic medical devices, achieving the top domestic market share in disposable traditional Korean medicine acupuncture needles and disposable cupping cups. Leveraging its automated production system and excellent technology, it exports products globally and continuously conducts R&D for product improvement and new market entry. It is headquartered in Boryeong-si, Chungcheongnam-do.